Search results

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program

ANSTO offers a diverse range of career opportunities within science, engineering, corporate services and trade disciplines.

Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

ANSTO has agreed to participate in an Australian trial of a review of research infrastructure access proposals in which applicants remain anonymous to aid the removal of structural barriers to the career progression of Women in STEM.

In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.

Publications and resources from the Powder Diffraction beamline.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.